Peptide-Mediated Cellular Delivery of Oligonucleotide-Based Therapeutics In Vitro: Quantitative Evaluation of Overall Efficacy Employing Easy to Handle Reporter Systems

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|34|3637-3655

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.34, 2008-12, pp. : 3637-3655

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: Delivery, Intracellular Trafficking, and Biological Effectiveness of Oligonucleotide-Based Therapeutics Executive Editor: A. Mescalchin and G. Sczakiel]

By  

Current Pharmaceutical Design, Vol. 14, Iss. 34, 2008-12 ,pp. : 3601-3602

Bentham Science Publishers

Access to resources Recommend Favorite

PTD/CPP Peptide-Mediated Delivery of siRNAs

By  

Current Pharmaceutical Design, Vol. 19, Iss. 16, 2013-05 ,pp. : 2943-2947

Bentham Science Publishers

Access to resources Recommend Favorite

Carrier Mediated Systemic Delivery of Protein and Peptide Therapeutics

By  

Current Pharmaceutical Design, Vol. 22, Iss. 40, 2016-12 ,pp. : 6167-6191

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular Delivery In Vivo of siRNA-Based Therapeutics

By  

Current Pharmaceutical Design, Vol. 14, Iss. 34, 2008-12 ,pp. : 3603-3619

Bentham Science Publishers

Access to resources Recommend Favorite

Oligonucleotide-based Gene Therapy for Cardiovascular Disease Are Oligonucleotide Therapeutics Novel Cardiovascular Drugs

By  

Current Drug Targets, Vol. 1, Iss. 1, 2000-07 ,pp. : 15-23

Bentham Science Publishers

Access to resources Recommend Favorite